Google Ads for Supplements and Peptides: What Gets You Banned vs. What Converts

Google Ads is the highest-intent advertising channel available to supplement and peptide brands. Someone searching "best NAD+ supplement" or "red light therapy panel reviews" is actively looking to buy. No other platform delivers that level of purchase intent at scale.

But Google is also the platform most likely to permanently ban your business from advertising. Their healthcare and supplement policies are strict, inconsistently enforced, and designed to err on the side of rejection. One wrong phrase in an ad headline, one non-compliant landing page element, one misunderstood policy section, and your account is suspended with limited recourse.

We have managed paid media for dozens of biohacking and supplement brands. We have seen accounts suspended for phrases that seem completely innocuous, and we have seen brands run aggressive campaigns for months without a single disapproval. The difference is never luck. It is always a systematic understanding of what Google actually enforces and how to structure campaigns that satisfy both the algorithm and the human reviewers.

Google's Misrepresentation Policy: The Rule That Bans Brands

Most supplement brands focus on Google's Healthcare and Medicines policy when trying to understand what they can and cannot advertise. That policy matters, but it is not the one that catches most brands. The policy that triggers the majority of supplement account suspensions is the Misrepresentation Policy.

Google's Misrepresentation Policy prohibits ads and landing pages that deceive users by omitting relevant information or giving misleading information about products, services, or businesses. For health advertisers, this is interpreted broadly. Any health claim that Google's review team considers unsubstantiated, exaggerated, or misleading falls under misrepresentation, not just healthcare policy violations.

Why This Distinction Matters

When your ad is disapproved under the Healthcare and Medicines policy, you can usually fix the specific violation and get the ad re-approved. When your account is suspended under the Misrepresentation Policy, the consequences are far more severe. Misrepresentation suspensions often result in account-level bans rather than ad-level disapprovals, and they are significantly harder to appeal.

Specific Trigger Phrases That Cause Instant Review or Ban

Through managing hundreds of campaigns in the supplement space, we have identified the phrases and patterns that consistently trigger either automated review flags or manual reviewer escalation:

• "Pharmaceutical grade" is one of the most reliable instant flags. This phrase implies a drug-level quality standard that supplements cannot legally claim. Google's system interprets it as misrepresentation of product quality.
• "Clinically proven" triggers a substantiation review. Unless you can point to published clinical trials on the specific product being advertised (not just individual ingredients), this will be flagged.
• "Doctor recommended" without verifiable substantiation is treated as a misleading endorsement claim.
• "FDA approved" applied to any supplement is an immediate policy violation, because the FDA does not approve dietary supplements.
• "Cures," "treats," "heals," "reverses" or any verb that implies therapeutic action on a disease or medical condition will flag both Misrepresentation and Healthcare policies simultaneously.
• Specific dosage instructions in ad copy or on landing pages receiving ad traffic, especially for injectable or reconstitutable products, signal that the product is being marketed as a drug rather than a supplement.
• Before-and-after claims with specific metrics ("lost 30 pounds in 6 weeks," "reduced inflammation by 60%") trigger misrepresentation review because Google requires substantiation for quantified outcome claims.

The pattern to recognize: Google does not just evaluate your ad copy. They evaluate your entire landing page, your website's other pages that are linked from the landing page, and even other ads in the same account. A compliant ad pointing to a non-compliant landing page will still get you suspended.

Product Categories: What's Open, Restricted, and Banned

Not all biohacking products face the same level of scrutiny on Google Ads. Understanding the tier system helps you allocate budget effectively and avoid wasting money on campaigns that will inevitably get shut down.

Tier 1: Generally Open (Low Restriction)

These product categories can typically be advertised on Google with standard compliance practices:

• Red light therapy panels and devices can be advertised as wellness devices without healthcare certification, provided you avoid medical treatment claims. Focus on general wellness, skin health support, and recovery.
• Blue light blocking glasses are treated as consumer electronics or accessories, not health products.
• Fitness tracking devices and wearables including HRV monitors, CGMs marketed for wellness (not diabetes management), and sleep trackers.
• Sauna blankets and cold plunge equipment when marketed for wellness and recovery rather than treatment of specific conditions.
• General wellness books, courses, and information products about biohacking topics.

Tier 2: Restricted (Certification Required)

These categories require Google's Healthcare Advertiser Certification and careful compliance management:

• Dietary supplements including vitamins, minerals, amino acids, and herbal products. You must have the certification, and all claims must be structure-function compliant.
• Nootropic supplements face additional scrutiny because cognitive enhancement claims are closely monitored. Stick to "supports focus" and "supports mental clarity" language.
• Protein powders and sports nutrition when making any performance claims beyond basic nutritional content.
• Probiotic and gut health supplements are permitted but claims about treating digestive conditions will be flagged.

Tier 3: Highly Restricted to Prohibited

These categories face severe restrictions or outright bans:

• Peptides marketed as research chemicals are effectively banned. Google treats these as unapproved pharmaceuticals regardless of your "for research use only" disclaimers.
• Injectable products of any kind cannot be advertised on Google. This includes peptide kits, bacteriostatic water bundles, and reconstitution supplies when marketed alongside peptide products.
• SARMs and similar compounds are prohibited under Google's pharmaceutical policy.
• Any product making weight loss claims with specific outcomes faces extreme scrutiny and frequent disapprovals.
• Testosterone boosters and hormone-related supplements can technically be advertised but face such frequent disapprovals that ROI is rarely positive on direct campaigns.

The strategic insight: If your product falls in Tier 3, do not waste budget trying to advertise it directly. Instead, advertise educational content or Tier 1/Tier 2 products and use those campaigns to build an audience you can retarget through other channels and nurture via email.

The Education-First Campaign Architecture

The most successful supplement and biohacking brands on Google Ads do not run direct-response product campaigns. They run education-first campaigns that generate leads through valuable content and convert those leads through nurture sequences. This approach consistently outperforms direct product advertising in restricted categories for three reasons.

First, educational content passes Google's review process at a dramatically higher rate than product pages. A landing page titled "The Complete Guide to NAD+ and Cellular Health" with a lead magnet will be approved when a product page for NAD+ capsules gets flagged. Second, educational landing pages generate higher quality leads because the visitor has self-selected as someone interested in learning, not just bargain-hunting. Third, the nurture sequence allows you to make more detailed product claims in email (where Google's policies do not apply) than you ever could on a landing page.

The Four-Stage Funnel

Stage 1: Search ad targeting educational keywords. Instead of bidding on "buy NAD+ supplement," bid on "NAD+ benefits research" or "how does NAD+ support cellular health." These keywords are cheaper, face less competition, and trigger fewer policy reviews.

Stage 2: Educational landing page with lead capture. The landing page provides genuine educational value: a comprehensive guide, a research summary, a comparison framework, or a checklist. The lead magnet is the gated version of this content (PDF, email series, or video course). This page includes the FDA structure-function disclaimer, privacy policy, and terms of service, but does not include direct product purchase options.

Stage 3: Email nurture sequence. Once the lead is captured, your email sequence can progressively introduce your products in context. Email is not subject to Google's advertising policies, so you have more flexibility in how you discuss your products (though FDA and FTC rules still apply). A typical nurture sequence for supplement buyers runs 7 to 14 emails over 3 to 4 weeks.

Stage 4: Conversion. The purchase happens on your website, driven by email, retargeting on other platforms, or organic return visits. By the time the lead reaches this stage, they have been educated on the category, they trust your brand as an authority, and they are ready to buy without needing aggressive sales copy.

Performance Comparison

Across our client portfolio, education-first campaigns in the supplement space consistently deliver the following performance advantages over direct product campaigns:

• 4x lower cost per lead because educational keywords have less competition and higher quality scores
• 90% fewer ad disapprovals because educational content passes policy review reliably
• 2.5x higher lifetime customer value because educated buyers have more realistic expectations and lower return rates
• Zero account suspensions across clients using this architecture properly, compared to regular suspensions for clients running direct product campaigns before working with us

Compliant Ad Copy That Actually Converts

Writing ad copy that satisfies Google's policies while still driving clicks and conversions is an art. Here are ten real examples showing the violation version, the compliant version, and why the compliant version often performs better.

Notice the pattern in the compliant versions. They lead with education and curiosity rather than direct outcome promises. They reference research and science rather than making definitive claims. They use "support" language instead of treatment verbs. And many of them include a content offer (free guide, research summary) that drives higher click-through rates than direct product headlines because they promise value without commitment.

In our testing, compliant ad copy consistently achieves click-through rates within 10 to 15% of aggressive non-compliant copy, while maintaining account health and avoiding the revenue disruption of suspensions. When you factor in the cost of account recovery and lost advertising days, the compliant approach generates significantly more revenue over any 12-month period.

Landing Page Compliance Checklist

Your ad copy can be perfectly compliant and you will still get suspended if your landing page does not meet Google's requirements. Here is exactly what Google's review team looks for when evaluating destination URLs for supplement and health product campaigns.

Required Elements

• FDA structure-function disclaimer. "These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease." This must be visible without scrolling past the first set of product claims. Burying it in the footer is not sufficient.
• Clear privacy policy linked from the landing page and accessible in one click.
• Terms of service linked from the landing page.
• Transparent pricing. If the landing page includes a product for sale, the price must be clearly displayed before the user enters the checkout flow. No hidden fees, no price revealed only after email capture.
• Return and refund policy accessible from the landing page. Google specifically checks for this on e-commerce pages.
• Physical business address or at minimum a contact page with a real way to reach the business. P.O. boxes are acceptable but a complete absence of contact information is a flag.
• Supplement Facts panel for any supplement product page, showing ingredients, dosages, and serving size.

Common Mistakes That Trigger Manual Review

• Testimonials with before-and-after photos. Meta bans these outright. Google allows them in limited contexts but they frequently trigger manual review, especially for supplement products.
• Autoplay video with health claims. Google's reviewers watch the videos on your landing pages. If the video makes claims that would be non-compliant as text, the page will be flagged.
• Pop-ups that obscure compliance information. If your exit-intent pop-up covers the FDA disclaimer or navigation to your privacy policy, reviewers will flag it.
• Links to non-compliant pages. If your landing page links to a blog post that makes drug claims, or to a product page with "pharmaceutical grade" language, the entire site can be flagged through association.
• Countdown timers and false urgency. "Only 3 left in stock" when you have thousands of units, or countdown timers that reset on page reload, are misrepresentation violations.
• Missing or hard-to-find subscription terms. If you offer a subscription product, the terms must be clearly stated before the purchase button. Hiding subscription details in fine print is one of the fastest paths to a misrepresentation suspension.

Pro tip: Before launching any campaign, open your landing page in a private browser window and go through it as a Google reviewer would. Can you find the price within 5 seconds? Is the FDA disclaimer visible near the claims? Can you reach the privacy policy, terms, and refund policy in one click? Is every claim on the page substantiated? If any answer is no, fix it before you launch.

What To Do If Your Account Gets Suspended

Even with perfect compliance, account suspensions happen. Google's automated systems produce false positives, manual reviewers make mistakes, and policy interpretations can shift without notice. If your account gets suspended, here is the step-by-step process we use for our clients.

Step 1: Do Not Create a New Account Immediately

Your first instinct will be to open a new Google Ads account and start running campaigns again. Do not do this. Google links accounts by payment method, IP address, business name, domain, and other signals. Opening a new account while suspended is a violation of Google's circumvention policy and will result in the new account being banned as well, making future appeals even harder.

Step 2: Identify the Specific Violation

Read the suspension notice carefully. Google categorizes suspensions by policy area: Misrepresentation, Healthcare and Medicines, Unapproved Pharmaceuticals, or others. The category determines your appeal strategy. Check your email for the specific notification, then review the policy page Google references in that notification.

Step 3: Audit and Fix Everything Before Appealing

Before you submit an appeal, fix every potential violation across your entire account and website. This means:

• Review every ad in the account, not just the ones that were flagged
• Audit every landing page receiving ad traffic
• Check every page linked from those landing pages
• Remove or revise all non-compliant claims, testimonials, and imagery
• Ensure all required compliance elements are in place (disclaimers, policies, pricing transparency)
• Pause any campaigns for Tier 3 products that cannot be made compliant

Step 4: Submit a Detailed Appeal

Google's appeal form is minimal, but your response should not be. Clearly describe what changes you have made, reference the specific policy that was violated, explain why the changes resolve the issue, and include screenshots or documentation showing the corrections. The more specific and professional your appeal, the higher your approval rate.

Step 5: Wait, Then Follow Up

Initial appeal reviews typically take 3 to 7 business days. If denied, you can appeal again with additional information. Most legitimate suspensions are resolved within two appeals if the underlying issues are genuinely fixed. If you are denied twice, request a manual review through Google Ads support chat. The third review is typically conducted by a senior reviewer.

Step 6: Know When to Start Fresh

If your account has been suspended multiple times, or if the suspension is for a category that you cannot make compliant (for example, if your core product is injectable peptides), it may be more effective to start with a new business entity, new domain, new payment method, and a completely compliant campaign structure from day one. This is a significant investment, but it is sometimes the only path forward for brands whose account history is too damaged to recover.

Timeline Expectations

• First appeal: 3 to 7 business days for a response
• Second appeal (if needed): 5 to 10 business days
• Manual review request: 7 to 14 business days
• Total recovery time (typical): 2 to 6 weeks from suspension to fully operational campaigns

Google Ads remains one of the most powerful customer acquisition channels for supplement and biohacking brands. The brands that succeed on the platform are not the ones with the biggest budgets or the most aggressive copy. They are the ones that build compliance into every layer of their campaign architecture, from keyword selection to ad copy to landing pages to the nurture sequence beyond.

If you want help building a compliant paid media strategy for your supplement or biohacking brand, start with our free brand scan to assess your current compliance posture, download our compliance checklist for a step-by-step framework, or book a discovery call to talk through your specific situation with our team.